| Contact us | |
| Return to database |
Prevalence (%) of clinical parameters based on data from 1 references describing 22 individuals
Add new symptom/sign to this disease
| Pubmed id number as a reference | Organ system affected | ||
| Number of patients in the reference | Percent affected patients (Between 0 and 1, eg. 0.1 = 10%) | ||
| Please provide your name and contact information as a reference | |||
| Name | Institute | Phone number | Email address |
List of symptoms
| Symptom/sign | Organ system | Percent affected | Pubmed id | Added on(yyyy-mm-dd) | Edit/add reference |
| Decreased motor nerve conduction velocity | nervous | 92 % | 20596894 | 2018-03-04 | |
| Gait disturbances | nervous | 73 % | 20596894 | 2018-03-04 | |
| Leukodystrophy | nervous | 62 % | 20596894 | 2018-03-04 | |
| Seizures | nervous | 45 % | 20596894 | 2018-03-04 | |
| Spasticity | nervous | 43 % | 20596894 | 2018-03-04 | |
| Pyramidal signs | nervous | 33 % | 20596894 | 2018-03-04 | |
| Developmental delay | nervous | 32 % | 20596894 | 2018-03-04 |
List of references:
Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy.
Osvaldo Artigalás, Valeska Lizzi Lagranha, Maria Luiza Saraiva-Pereira, Maira Graeff Burin, Charles Marques Lourenço, Hélio van der Linden, Mara Lúcia Ferreira Santos, Sergio Rosemberg, Carlos Eduardo Steiner, Fernando Kok, Carolina F Moura de Souza, Laura B Jardim, Roberto Giugliani, Ida Vanessa Schwartz,
Journal of inherited metabolic disease - Dec 2010